Physician profile
Robert Tyrrell
NPI 1912906561
$1,843.51
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $207 · 2021: $16.61 · 2022: $74.79 · 2023: $462 · 2024: $579 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.98 | 2019-2020 | |
| Averitas Pharma INC. | $249.98 | 2023-2024 | Qutenza |
| Medtronic, INC. | $162.84 | 2024 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $160.97 | 2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $141.60 | 2021-2023 | Nuzyra |
| Smith+Nephew, INC. | $120.91 | 2023 | Stravix, Oasis, Grafix |
| Amgen INC. | $120.29 | 2024 | Krystexxa |
| Ani Pharmaceuticals, INC. | $117.99 | 2024 | Purified Cortrophin Gel |
| Zimmer Biomet Holdings, INC. | $105.87 | 2019 | |
| Nevro Corp. | $91.04 | 2023 | Senza |
| Grt US Holding, INC. | $74.79 | 2022 | |
| Organogenesis INC. | $53.25 | 2024 | Affinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tyrrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.